Top compounds associated with response to PBX4


Feature Type Standardized
Nominal ANOVA
mRNA AZD6244 CCLE pan-cancer AAC -0.094 0.04
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.067 0.04
mRNA DMOG GDSC1000 pan-cancer AAC -0.066 0.04
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.072 0.04
mRNA Imatinib CTRPv2 pan-cancer AAC -0.074 0.04
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.063 0.04
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
mRNA azacitidine CTRPv2 pan-cancer AAC -0.075 0.05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.05
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.073 0.05
Download CSV